Geode Capital Management’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-32,094
Closed -$468K 4867
2023
Q1
$468K Hold
32,094
﹤0.01% 3670
2022
Q4
$234K Hold
32,094
﹤0.01% 4012
2022
Q3
$222K Buy
32,094
+2,215
+7% +$16.5K ﹤0.01% 4150
2022
Q2
$208K Hold
29,879
﹤0.01% 4239
2022
Q1
$246K Sell
29,879
-249
-0.8% -$2.25K ﹤0.01% 4276
2021
Q4
$325K Sell
30,128
-53
-0.2% -$572 ﹤0.01% 4258
2021
Q3
$364K Buy
30,181
+20,139
+201% +$227K ﹤0.01% 4176
2021
Q2
$121K Buy
+10,042
New +$125K ﹤0.01% 4505

Geode Capital Management's AMYT Position: Q2 2023 in Review

Geode Capital Management sold out of Amryt Pharma plc American Depositary Shares (AMYT) in Q2 2023, closing a stake of 32,094 shares — an estimated $468K sold.

Geode Capital Management first reported a position in AMYT in Q2 2021 and held it in 8 quarters. The position peaked at $468K in Q1 2023. 0 funds tracked by Wall St. Rank hold AMYT as of Q2 2023.

  • Geode Capital Management reported no remaining Amryt Pharma plc American Depositary Shares position as of Q2 2023 after selling out during the quarter.
  • Geode Capital Management sold 32,094 Amryt Pharma plc American Depositary Shares shares in Q2 2023, an estimated $468K.
  • Geode Capital Management first reported a position in Amryt Pharma plc American Depositary Shares in Q2 2021 and held it in 8 quarters.
  • Geode Capital Management's Amryt Pharma plc American Depositary Shares position peaked at $468K in Q1 2023.
  • 0 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q2 2023.

Based on Geode Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.